Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Details)

v3.23.1
Related Party Transactions (Details)
 12 Months Ended
Apr. 08, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
Director
shares
Dec. 31, 2021
USD ($)
Dec. 01, 2022
USD ($)
Pre-Merger Financing and Waiver Agreements [Abstract]        
Number of directors signed waiver agreements | Director   6    
Consulting fee payable in cash | $       $ 25,000
Director [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Consulting fee payable in cash | $ $ 10,000      
Number of stock option granted (in shares) | shares 50,000      
Vesting period   36 months    
Consulting expenses | $   $ 105,000 $ 0  
Consulting expenses unpaid | $   $ 25,000    
Director [Member] | Vesting on March 31, 2023 [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Vesting percentage 25.00%      
Pre-Merger Financing [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Number of directors | Director   5    
Amount invested in pre-merger financing | $   $ 300,000    
Number of converted initial shares received by directors (in shares) | shares   17,729    
Number of converted additional shares (in shares) | shares   53,189    
Pre-Merger Financing [Member] | Rexahn [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Number of directors | Director   1    
Pre-Merger Financing [Member] | Series A Warrants [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Number of converted additional shares (in shares) | shares   80,366    
Pre-Merger Financing [Member] | Series B Warrants [Member]        
Pre-Merger Financing and Waiver Agreements [Abstract]        
Number of converted additional shares (in shares) | shares   9,444